Corindus Vascular Robotics Inc (CVRS) Major Shareholder Acquires $4,001,159.58 in Stock
Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) major shareholder Hudson Executive Capital Lp purchased 2,899,391 shares of the firm’s stock in a transaction on Tuesday, March 12th. The shares were acquired at an average price of $1.38 per share, with a total value of $4,001,159.58. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
Shares of Corindus Vascular Robotics stock opened at $1.98 on Friday. Corindus Vascular Robotics Inc has a 1-year low of $0.70 and a 1-year high of $2.01.
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last issued its quarterly earnings results on Tuesday, March 12th. The medical equipment provider reported ($0.04) earnings per share for the quarter, hitting the Zacks’ consensus estimate of ($0.04). The business had revenue of $4.67 million for the quarter, compared to analyst estimates of $5.60 million.
Corindus Vascular Robotics Company Profile
Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.
Recommended Story: What is dollar cost averaging (DCA)?
Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.